SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours

Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors

(2012) Amit K Mitra et al.   PHARMACOGENOMICS

A novel method for quantification of gemcitabine and its metabolites 2′,2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with 19F NMR spectroscopy

(2011) Tashinga E. Bapiro et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine

(2011) M. Joerger et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Combinatorial Pharmacologic Effects of Gemcitabine and its Metabolite dFdU

(2011) Alexey Benyumov et al.   ChemMedChem

A Polymorphism in the Cytidine Deaminase Promoter Predicts Severe Capecitabine-Induced Hand-Foot Syndrome

(2011) D. Caronia et al.   CLINICAL CANCER RESEARCH

The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C

(2010) Ekkaphon METHAROM et al.   Asia-Pacific Journal of Clinical Oncology

Inactivation ofLactobacillus leichmanniiRibonucleotide Reductase by 2′,2′-Difluoro-2′-deoxycytidine 5′-Triphosphate: Covalent Modification

(2010) Gregory J. S. Lohman et al.   BIOCHEMISTRY

Clinical pharmacology and pharmacogenetics of gemcitabine

(2009) Andrea Wong et al.   DRUG METABOLISM REVIEWS

Synthesis of gemcitabine triphosphate (dFdCTP) as a tris(triethylammonium) salt

(2008) Prabhakar A. Risbood et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Does saturable formation of gemcitabine triphosphate occur in patients?

(2008) Lai-San Tham et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

(2008) C. Tibaldi et al.   CLINICAL CANCER RESEARCH

Adrenocortical carcinoma survival rates correlated to genomic copy number variants

(2008) E. A. Stephan et al.   MOLECULAR CANCER THERAPEUTICS

Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate

(2007) Xuemin Jiang et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY